Provided by Tiger Trade Technology Pte. Ltd.

Nurix Therapeutics

14.76
-0.7700-4.96%
Pre-market: 15.000.2400+1.63%04:44 EDT
Volume:1.18M
Turnover:17.60M
Market Cap:1.52B
PE:-4.84
High:15.55
Open:15.35
Low:14.75
Close:15.53
52wk High:22.50
52wk Low:8.18
Shares:102.84M
Float Shares:86.36M
Volume Ratio:0.55
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.0514
EPS(LYR):-3.0514
ROE:-49.63%
ROA:-26.30%
PB:2.82
PE(LYR):-4.84

Loading ...

Nurix Therapeutics Appoints Roger Dansey to Board of Directors

Reuters
·
Nov 10, 2025

Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.d., to Its Board of Directors

THOMSON REUTERS
·
Nov 10, 2025

Nurix Therapeutics (NRIX) Gets a Buy from Oppenheimer

TIPRANKS
·
Nov 08, 2025

BRIEF-Nurix Therapeutics Presents New Translational Data from First-in-Human Clinical Trial of Oral CBL-B Inhibitor NX-1607 Demonstrating Immune Activation and Tumor Microenvironment Remodeling

Reuters
·
Nov 07, 2025

Nurix Therapeutics Price Target Maintained With a $27.00/Share by BTIG

Dow Jones
·
Nov 04, 2025

Nurix Therapeutics’ Bexodeg: Promising Efficacy and Safety Profile Drive Buy Rating

TIPRANKS
·
Nov 04, 2025

Nurix Therapeutics CFO Hans van Houte Reports Sale of Common Shares

Reuters
·
Nov 04, 2025

Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire
·
Nov 03, 2025

Truist Financial Remains a Buy on Nurix Therapeutics (NRIX)

TIPRANKS
·
Oct 30, 2025

Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Oct 28, 2025

Nurix Therapeutics’ NX-5948 Study: A Potential Game-Changer in Drug Delivery

TIPRANKS
·
Oct 28, 2025

Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock

GlobeNewswire
·
Oct 27, 2025

Piper Sandler Sticks to Its Buy Rating for Nurix Therapeutics (NRIX)

TIPRANKS
·
Oct 23, 2025

RBC Raises Price Target on Nurix Therapeutics to $29 From $28, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Oct 23, 2025

Nurix Therapeutics price target lowered to $21 from $22 at Wells Fargo

TIPRANKS
·
Oct 23, 2025

U.S. RESEARCH ROUNDUP-Avery Dennison, Expedia Group, Hologic

Reuters
·
Oct 23, 2025

Nurix Therapeutics Inc : Btig Cuts Target Price to $27 From $35

THOMSON REUTERS
·
Oct 23, 2025

Nurix Therapeutics price target raised to $29 from $28 at RBC Capital

TIPRANKS
·
Oct 23, 2025

Nurix Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
Oct 23, 2025

Nurix Therapeutics Inc - Proceeds to Fund Bexobrutideg Development in Cll and Autoimmune

THOMSON REUTERS
·
Oct 22, 2025